BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31613396)

  • 1. Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.
    Kittaka M; Yoshimoto T; Schlosser C; Rottapel R; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2020 Feb; 35(2):382-395. PubMed ID: 31613396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
    Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
    J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
    Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice.
    Kittaka M; Yoshimoto T; Schlosser C; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
    JBMR Plus; 2020 Jun; 4(6):e10352. PubMed ID: 32537546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
    Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
    Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased SH3BP2 inhibits osteoclast differentiation and function.
    Kawamoto T; Fan C; Gaivin RJ; Levine MA; Lietman SA
    J Orthop Res; 2011 Oct; 29(10):1521-7. PubMed ID: 21448930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of IL-34 and anti-IL-34 neutralizing mAb on alveolar bone loss in a ligature-induced model of periodontitis.
    Duarte C; Yamada C; Ngala B; Garcia C; Akkaoui J; Birsa M; Ho A; Nusbaum A; AlQallaf H; John V; Movila A
    Mol Oral Microbiol; 2024 Jun; 39(3):93-102. PubMed ID: 37902168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
    Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
    J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
    Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.
    Mukai T; Gallant R; Ishida S; Yoshitaka T; Kittaka M; Nishida K; Fox DA; Morita Y; Ueki Y
    PLoS One; 2014; 9(8):e105518. PubMed ID: 25144740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-Specific PTP1B Deficiency Attenuates Inflammation-Induced and Ovariectomy-Induced Bone Loss in Mice by Inhibiting Osteoclastogenesis.
    Kim HJ; Ryu KY; Kim YG; Kim MO; Lee JH; Song MK; Youn YJ; Pokhrel NK; Kim SH; Kim JY; Jung HJ; Kim WS; Hong CW; Kim HH; Lee Y
    J Bone Miner Res; 2022 Mar; 37(3):505-514. PubMed ID: 34812548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo.
    Ihn HJ; Kim YS; Lim S; Bae JS; Jung JC; Kim YH; Park JW; Wang Z; Koh JT; Bae YC; Baek MC; Park EK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocyte RANKL Drives Bone Resorption in Mouse Ligature-Induced Periodontitis.
    Kittaka M; Yoshimoto T; Levitan ME; Urata R; Choi RB; Teno Y; Xie Y; Kitase Y; Prideaux M; Dallas SL; Robling AG; Ueki Y
    J Bone Miner Res; 2023 Oct; 38(10):1521-1540. PubMed ID: 37551879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage-inducible transcript 3 deficiency promotes bone resorption in murine periodontitis models.
    Luo Y; Yang B; Dong W; Yu W; Jia M; Wang J
    J Periodontal Res; 2023 Aug; 58(4):841-851. PubMed ID: 37243354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
    Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
    Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING inhibition alleviates bone resorption in apical periodontitis.
    Mao HQ; Zhou L; Li JQ; Wen YH; Chen Z; Zhang L
    Int Endod J; 2024 Jul; 57(7):951-965. PubMed ID: 38411951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum stress response and bone loss in experimental periodontitis in mice.
    Yamada H; Nakajima T; Domon H; Honda T; Yamazaki K
    J Periodontal Res; 2015 Aug; 50(4):500-8. PubMed ID: 25223277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
    Fujita S; Mukai T; Mito T; Kodama S; Nagasu A; Kittaka M; Sone T; Ueki Y; Morita Y
    Bone; 2018 Jan; 106():156-166. PubMed ID: 29055830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.